FDA for approval to treat VTE and to prevent VTE in children
The Pharma Data
JUNE 28, 2021
There are currently no FDA-approved anticoagulation therapies for pediatric patients with congenital heart disease who have undergone the Fontan procedure. Xarelto is approved in more than 130 countries, although the approved labelling, including the number of indications may differ from country to country.
Let's personalize your content